Share price
$1.35
As of Apr 29, 2026
MGX | NASDAQ
Metagenomi Therapeutics, Inc.
Metagenomi Therapeutics, Inc. (MGX) | runway 39.3 months | financing risk lower | market cap $54.2M. Daily snapshot of financials, capital pressure, and rece...
Company websiteLast updated Apr 29, 2026
Market cap
$54.2M
Snapshot valuation
30D volume
192,804 shares
Rolling average daily volume
Runway
39.3 months
Estimated from precomputed burn and cash
Financing risk
N/A
Current liquidity and recent financing activity do not point to an immediate capital raise.
Snapshot summary
Runway: 39.3 months based on estimated burn.
Financing signal: Current liquidity and recent financing activity do not point to an immediate capital raise.
Latest development: Metagenomi Therapeutics, Inc. 8-K 2026-03-05.
Recent developments
Metagenomi Therapeutics, Inc. 8-K 2026-03-05
8-K filed on 2026-03-05.
Metagenomi Therapeutics, Inc. 10-K 2026-03-05
10-K filed on 2026-03-05.
Metagenomi Therapeutics, Inc. 8-K 2026-01-12
8-K filed on 2026-01-12.
Metagenomi Therapeutics, Inc. 8-K 2025-11-12
8-K filed on 2025-11-12.
Metagenomi Therapeutics, Inc. 10-Q 2025-11-12
10-Q filed on 2025-11-12.
Related screens
Low cash runway companies
Companies screening with the shortest estimated runway based on precomputed burn and cash snapshots.
High burn rate companies
Companies with the highest estimated trailing cash burn across the monitored issuer set.
Recent financing disclosures
Companies with recent financing activity, capital raises, or post-balance-sheet funding events.
Pre-market filings
Companies with recent filings or disclosures posted before the market open.
Related companies
Recent documents
Metagenomi Therapeutics, Inc. 8-K 2026-03-05
8-K filed on 2026-03-05.
Mar 4, 2026Open source
Metagenomi Therapeutics, Inc. 10-K 2026-03-05
10-K filed on 2026-03-05.
Mar 4, 2026Open source
Metagenomi Therapeutics, Inc. 8-K 2026-01-12
8-K filed on 2026-01-12.
Jan 11, 2026Open source
Metagenomi Therapeutics, Inc. 8-K 2025-11-12
8-K filed on 2025-11-12.
Nov 11, 2025Open source
Premium analysis
Full filing analysis and proprietary signal detail
Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.
Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures